Innovative Financial Statements From 2010 to 2024

002173 Stock   8.09  0.55  6.37%   
Innovative Medical financial statements provide useful quarterly and yearly information to potential Innovative Medical Management investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Innovative Medical financial statements helps investors assess Innovative Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Innovative Medical's valuation are summarized below:
Gross Profit
46.2 M
Profit Margin
(0.06)
Market Capitalization
3.7 B
Enterprise Value Revenue
4.0091
Revenue
808.8 M
We have found eighty available fundamental trends for Innovative Medical, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Innovative Medical regular market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Innovative Medical Total Revenue

550.5 Million

Check Innovative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Innovative Medical's main balance sheet or income statement drivers, such as Interest Expense of 4.2 M, Selling General Administrative of 40.6 M or Total Revenue of 550.5 M, as well as many indicators such as . Innovative financial statements analysis is a perfect complement when working with Innovative Medical Valuation or Volatility modules.
  
This module can also supplement various Innovative Medical Technical models . Check out the analysis of Innovative Medical Correlation against competitors.

Innovative Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.9 B2.3 B2.2 B
Slightly volatile
Other Current Liabilities45.3 K47.7 K50.3 M
Pretty Stable
Total Current Liabilities442.5 M325.4 M455 M
Very volatile
Total Stockholder Equity1.4 B1.9 B1.7 B
Slightly volatile
Accounts Payable218.5 M208.1 M103.6 M
Slightly volatile
Cash314.9 M563.1 M382 M
Slightly volatile
Net Receivables136.7 M102.8 M143.1 M
Very volatile
Inventory39.7 M41.8 M344.8 M
Slightly volatile
Other Current Assets1.1 M1.1 M59.1 M
Very volatile
Total Liabilities525.7 M410.4 M560.7 M
Pretty Stable
Intangible Assets136 M129.6 M83 M
Slightly volatile
Common Stock547.7 M521.7 M354.8 M
Slightly volatile
Property Plant Equipment1.7 B1.6 B848.9 M
Slightly volatile
Other Assets88.8 M84.5 M57 M
Slightly volatile
Long Term Debt7.7 M8.1 M39.7 M
Slightly volatile
Other Liabilities54.8 M104.1 M60.4 M
Slightly volatile
Net Tangible Assets2.2 B2.1 B1.5 B
Slightly volatile
Other Stockholder Equity9.4 M13.1 MM
Slightly volatile
Deferred Long Term Liabilities63.5 M60.4 M23.2 M
Slightly volatile
Long Term Investments16.3 M21.5 M12.9 M
Slightly volatile
Short and Long Term Debt28.7 M30.2 M43 M
Pretty Stable
Total Current Assets1.1 B733.1 M1.2 B
Very volatile
Short Term Debt152.6 M247.2 M121 M
Slightly volatile
Non Current Assets Total1.5 B1.5 BB
Slightly volatile
Non Currrent Assets Other1.7 M1.8 M39.6 M
Slightly volatile
Non Current Liabilities Total129.2 M85 M190.9 M
Slightly volatile
Non Current Liabilities Other15.2 M16 M35.2 M
Slightly volatile
Common Stock Shares Outstanding363 M449 M448.7 M
Slightly volatile
Short Term Investments17.2 M18.1 M504.7 M
Slightly volatile
Net Invested Capital2.1 B1.9 B3.2 B
Slightly volatile
Net Working Capital669.6 M407.6 M1.1 B
Slightly volatile
Capital Stock362.7 M449 M448.1 M
Slightly volatile
Property Plant And Equipment Net1.1 B1.3 B1.4 B
Slightly volatile
Property Plant And Equipment Gross1.5 B2.1 B1.9 B
Slightly volatile
Capital Lease Obligations24.1 M20.3 M39.4 M
Slightly volatile

Innovative Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative40.6 M37.7 M41.6 M
Pretty Stable
Total Revenue550.5 M805.6 M573.9 M
Slightly volatile
Cost Of Revenue417 M713.4 M441 M
Slightly volatile
Research Development2.2 M2.7 MM
Slightly volatile
Gross Profit120.8 M92.2 M114 M
Very volatile
Other Operating Expenses4.8 M3.3 M5.2 M
Very volatile
Total Operating Expenses782.7 M839.8 M527.6 M
Slightly volatile
Interest Income11.4 M17.4 M10.5 M
Pretty Stable
Reconciled Depreciation116 M106.7 M100.1 M
Slightly volatile

Innovative Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Dividends Paid1.4 M1.5 M19.8 M
Slightly volatile
Depreciation101.5 M106.7 M65.1 M
Slightly volatile
End Period Cash Flow482.6 M249 M887.7 M
Slightly volatile
Begin Period Cash Flow523.1 M658.3 M962.7 M
Slightly volatile
Other Non Cash Items16.6 M10 M24.9 M
Slightly volatile

About Innovative Medical Financial Statements

Innovative Medical stakeholders use historical fundamental indicators, such as Innovative Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Innovative Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Innovative Medical's assets and liabilities are reflected in the revenues and expenses on Innovative Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Innovative Medical Management. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue805.6 M550.5 M
Cost Of Revenue713.4 M417 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Innovative Stock

Innovative Medical financial ratios help investors to determine whether Innovative Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innovative with respect to the benefits of owning Innovative Medical security.